MAXIMUS‘ (NYSE: MMS) U.K. subsidiary has been selected for a potential five-year contract to assess individuals in the country that apply for disability benefits.
The U.K.’s department for work and pensions will use MAXIMUS’ assessment results to determine an applicant’s eligibility to various health and disability benefits, the company announced Thursday.
Reuters first reported the contract Tuesday and pegged the value at around $806 million.
“Our goal is to improve the overall customer experience by addressing certain challenges that exist today, ” said Richard Montoni, MAXIMUS CEO.
Montoni added that MAXIMUS will work to minimize waiting times with hires of additional healthcare professionals, as well as to help customers complete forms and seek independent advice.
MAXIMUS will start work with a four-month transition period before the company begins the three-year base period of performance on March 1, 2015.
The contract contains two option years.